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Multiday acute sodium bicarbonate intake
improves endurance capacity and reduces
acidosis in men
Sandro Manuel Mueller1, Saskia Maria Gehrig1, Sebastian Frese1,2, Carsten Alexander Wagner3,4,
Urs Boutellier1,3,4 and Marco Toigo1,3,4*
Abstract
Background: The purpose was to investigate the effects of one dose of NaHCO3 per day for five consecutive days
on cycling time-to-exhaustion (Tlim) at ‘Critical Power’ (CP) and acid–base parameters in endurance athletes.
Methods: Eight trained male cyclists and triathletes completed two exercise periods in a randomized, placebo-controlled,
double-blind interventional crossover investigation. Before each period, CP was determined. Afterwards, participants
completed five constant-load cycling trials at CP until volitional exhaustion on five consecutive days, either after a dose
of NaHCO3 (0.3 g·kg
−1 body mass) or placebo (0.045 g·kg−1 body mass NaCl).
Results: Average Tlim increased by 23.5% with NaHCO3 supplementation as compared to placebo (826.5 ± 180.1 vs.
669.0 ± 167.2 s; P = 0.001). However, there was no time effect for Tlim (P = 0.375). [HCO3
−] showed a main effect for
condition (NaHCO3: 32.5 ± 2.2 mmol·l
−1; placebo: 26.2 ± 1.4 mmol·l−1; P < 0.001) but not for time (P = 0.835). NaHCO3
supplementation resulted in an expansion of plasma volume relative to placebo (P = 0.003).
Conclusions: The increase in Tlim was accompanied by an increase in [HCO3
−], suggesting that acidosis might be a
limiting factor for exercise at CP. Prolonged NaHCO3 supplementation did not lead to a further increase in [HCO3
−] due
to the concurrent elevation in plasma volume. This may explain why Tlim remained unaltered despite the prolonged
NaHCO3 supplementation period. Ingestion of one single NaHCO3 dose per day before the competition during
multiday competitions or tournaments might be a valuable strategy for performance enhancement.
Trial registration: ClinicalTrials.gov Identifier: NCT01621074
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Background
Competitive sports performance is strongly dependent
on optimal muscle function. During cycling exercise
across the heavy and severe intensity domains [1], energy
is provided more and more by anaerobic glycolysis. This
leads to an increased rate of accumulation of metabolites,
which have been linked with muscle fatigue (e.g. Pi, ADP,
H+, and extracellular K+). Cycling exercise at the threshold
between the heavy and severe domain, i.e. at ‘Critical
Power’ (CP), can, in contrast to the theoretical concept
[2], only be sustained for as long as 20 to 40 min [3]
before task failure. Furthermore, it was shown that CP
overestimates the highest possible metabolic steady state
[4,5] and, consequently, that exercise at or above CP is
associated with a decline in muscle and blood pH [6,7].
An activity-induced decrease in intracellular pH has been
suggested to limit exercise because it inhibits glycogenolysis
and glycolysis [8], increases muscular K+-release [9] and
inhibits sarcoplasmatic Ca2+-release [10,11]. Furthermore,
it induces a metabolic acidosis that might impair muscle
function [12] and compromise performance. To blunt the
fall in intracellular pH and prolong time-to-exhaustion
(Tlim), nutritional modulation might be a promising
avenue. With respect to endurance exercise, to date
especially sodium bicarbonate (NaHCO3) has gained
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much attention. However, the mechanisms by which
NaHCO3 ingestion may enhance performance are not
fully understood. It is believed that NaHCO3 ingestion
leads to an increase in blood bicarbonate concentration
([HCO3
−]), which in turn increases extracellular buffer
capacity. More precisely, it is proposed that the higher
[HCO3
−] gradient between blood and the intramyocellular
compartment enhances H+-efflux out of the muscle cell,
thereby delaying the fall in intracellular pH [13], which in
turn may delay an impairment in optimal muscle function
and performance [14,15]. Therefore, NaHCO3 supplemen-
tation would be expected to improve Tlim at CP if muscle
pH is a limiting factor for exercise tolerance.
Basically, three types of NaHCO3 supplementation
protocols can be applied: acute (single dose), chronic
(multiple dose) and multiday acute supplementation
(one dose per day before competition for consecutive
days of competition). During the acute delivery mode
participants take one single dose (mostly 0.3 g∙ kg−1
body mass NaHCO3) 60 to 90 min before the start of
competition. During the chronic delivery mode partici-
pants take a daily amount of NaHCO3 (mostly 0.5 g∙ kg
−1
body mass), divided in 2 to 3 portions, for several days
before competition takes place. On the day of competition,
no NaHCO3 is consumed [16,17]. The multiday acute
delivery mode comprises the ingestion of acute doses on
consecutive days of competition. In contrast to the chronic
loading protocol, acid–base balance is perturbed on every
day during the multiday acute delivery mode. This fact
leads to major differences regarding the acid–base
status and accordingly the underlying mechanisms as
well as the effectiveness of the different delivery modes.
While the acute and chronic supplementation protocols
are scientifically well described, data on the effects of
multiday acute supplementation are lacking. There are
several studies, which investigated NaHCO3 ingestion
during tournament-like sports, but only for single events.
For example, it was shown that NaHCO3 supplementation
increases tennis performance [18] but does not affect
prolonged intermittent cycling exercise performance [19].
However, up to date, no study investigated the effect of a
consecutive multiday supplementation on consecutive
multiday performance. Since consecutive, acute-load daily
use of NaHCO3 might represent an interesting option to
increase performance during multiday competitions or
tournaments that involve exercise in the heavy and severe
intensity domains, further research is warranted. In
particular, scientific knowledge is limited with respect to
the recovery of the body’s acid–base balance after
high-intensity exercise with NaHCO3 supplementation
and consequently, the initial positions on the following
days remain elusive.
Thus, the purpose of this randomized, placebo-controlled,
double-blind interventional crossover study was to
investigate if multiday acute NaHCO3 supplementation in
well-trained endurance athletes leads to changes in Tlim at
CP during constant-load cycle ergometer trials on a
day-to-day basis with daily acute NaHCO3 vs. placebo
supplementation for 5 days. Furthermore, we aimed to
investigate if differences in Tlim can be explained by
alterations in [HCO3
−] and if the high amount of ingested
Na+ influences plasma volume (PV) and thus [HCO3
−].
Given that exercise at or above CP leads to muscle and
blood acidification [6,7], and that [HCO3
−] increases
extracellular buffer capacity [13], we hypothesized that
consecutive, acute-load daily supplementation of NaHCO3
increases Tlim relative to placebo. We assumed that an
increase in [HCO3
−] after the first intake is responsible for
the rise in Tlim. Since during multiday NaHCO3 intake, a
high amount of Na+ is ingested and absorbed, detrimental
effects on endurance performance are possible. In fact, a
higher [Na+] leads to water retention and thereby results
in PV expansion [20]. An increase in PV decreases blood
ion concentrations, and as such results in a diminished
[HCO3
−], which in turn could counteract the benefits
associated with NaHCO3 intake. It is therefore questionable,
whether [HCO3
−] can be increased beyond the concentra-
tion reached after the first day of supplementation on all
subsequent days of supplementation. Consequently, we
hypothesized that PV expands following a high Na+
intake, limiting any further increase in [HCO3
−], and
consequently Tlim, beyond that observed after the first day
of supplementation.
Methods
Participants
Eleven well-trained male cyclists and triathletes volunteered
to participate in this study. The participants were recruited
from different cycling or triathlon clubs. Two of them were
excluded from the analysis because they contravened our
instructions. One participant did not refrain from
high-intensity exercise and the other markedly increased
the training volume during or before the second testing
sessions (see below). Another participant had to abort the
measurements because of illness. The physical characteris-
tics of the remaining eight participants were (mean ± SD)
age 31.4 ± 8.8 years, height 184.6 ± 6.5 cm, body mass
74.1 ± 7.4 kg, peak power output (Ppeak) during ramp
test 402.0 ± 29.1 W, peak oxygen uptake (V̇ O2peak)
61.0 ± 4.3 ml∙ kg−1∙ min−1. These athletes were all involved
in their early preparation phase of training (pre-season).
During this phase, the training consisted of constant-load
rides at low-intensity. The participants were instructed to
maintain their individual, low-intensity training programs.
Additionally, they were advised to refrain from any
high-intensity exercise during the testing sessions and
to continue their nutritional habits. The determination of
CP after the wash-out phase served to ascertain that no
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training effect occurred during the first phase of the study.
None of the participants included was currently using
buffer substances or any other ergogenic agents that
may have compromised the administration of NaHCO3.
Participants were fully informed about the purposes,
benefits and risks associated with this study and completed
a routine health questionnaire before giving written
informed consent. This study was approved by the Swiss
Federal Institute of Technology Zurich (ETH) ethics
committee and was conducted in accordance with the
Declaration of Helsinki.
Experimental overview
Using a randomized, placebo-controlled, double-blind
interventional crossover design, all participants completed
two exercise periods, each consisting of ten testing
sessions (Figure 1). These periods were separated by
at least one week and on average 2.3 ± 2.1 weeks of
washout, during which the participants maintained their
low-intensity training programs. During both periods, the
first five tests were conducted to determine CP and
consisted of one incremental test and four constant-load
tests to volitional exhaustion. The determination of CP
was followed by a five-day intervention period, which was
conducted either with NaHCO3 or sodium chloride
(NaCl) supplementation. On each day during the inter-
vention period, a constant-load trial at CP was performed.
All tests were carried out under temperature-controlled
laboratory conditions (19–24°C) and at the same time of
day. The participants had a 23 h 34 min ± 53 min and
23 h 22 min ± 45 min rest period between the single tests
during the placebo and NaHCO3 trials, respectively. All test
devices were calibrated before, and whenever indicated
after each test under the terms of the manufacturer’s
recommendations. An independent researcher randomly
assigned the two conditions to the participants and
administered the non-distinguishable placebo or NaHCO3
tablets without revealing the ingredient. The investigator
performing the tests was also blinded to the treatment. No
feedback on test performance was given to the participants
until all trials had been finished.
Supplementation
NaHCO3 was administered orally as tablets (Bullrich
Salz Magentabletten, delta pronatura Dr. Krauss &
Dr. Beckmann, Egelsbach, Germany). The NaHCO3
and placebo tablets (NaCl, delta pronatura Dr. Krauss &
Dr. Beckmann, Egelsbach, Germany) were matched by
shape and taste. During the two conditions either 0.3 g·kg−1
body mass of NaHCO3 or 0.045 g∙ kg
−1 body mass of
NaCl [21,22] had to be ingested 90 min before [17]
each of the five consecutive constant-load trials. Each
supplement was consumed during a 15-min period
with 0.75 dm3 still water to minimize gastrointestinal
discomfort or any other adverse effects [8,23]. One
NaHCO3 tablet contained 850 mg of NaHCO3,
whereas one placebo tablet contained 130 mg of
NaCl, which assured the intake of equal number of pills
during the varying conditions (i.e. 0.35 tablets∙ kg−1 body
mass). If a participant’s body mass was such that they
required to consume a non-round number of tablets, the
participants were instructed to consume the number of
pills rounded to the nearest whole pill required to obtain
the dose. To minimize falsification of the pill count,
participants were given an unknown (to them) number of
pills in excess of needs and were asked to return any
remaining pills at the end of the study.
Determination of ‘critical power’
Five cycle ergometer tests were performed to determine
CP [24]. On the first visit, the seat and handle bar of the
cycle ergometer (Ergoselect 200 K, Ergoline, Bitz,
Germany) were adjusted. These settings were adopted for
all consecutive trials. Participants started with a ramp
cycle ergometer test to determine Ppeak and V̇ O2peak.
After a 3-min rest, the ramp test started at 100 W and
involved power increases of 9 W every 18 s (30 W∙ min−1)
until volitional exhaustion. For all tests, participants were
asked to maintain a cadence of 80 revolutions per min
throughout the test. Volitional exhaustion, i.e. task failure,
for all cycling tests was defined as the point in time when
participants stopped pedaling or the cadence fell below 75
revolutions per minute for > 5 s. On each of the following
testing days, one constant-load trial at different power
Figure 1 Study design. C, constant-load trials at ‘Critical Power’ (CP); E, constant load tests; R, incremental ramp test.
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output was completed to determine CP. After a 3-min
rest, participants started with a 5-min warm-up at 75 W
[25]. The power was then increased immediately to 85%,
90%, 95% or 105% of Ppeak in a randomized order
(modified from Brickley et al. [25] including the 85%
stage). These endurance capacity tests were conducted
until task failure. Using the Tlim from these tests, CP
was then calculated from the linear power−time−1
equation [24].
Constant-load cycling trials at ‘critical power’
During each of the two intervention periods, five
constant-load trials at CP were completed on five
consecutive days. These trials started with a 3-min
rest and were followed by a 5-min warm-up at 75 W.
Subsequently, power was immediately increased to the
previously calculated CP and participants were encouraged
to maintain the given cadence for as long as possible.
Gas exchange and heart rate analysis
Participants were equipped with a facemask, which
covered their mouth and nose (Hans Rudolph, Shawnee,
KS, USA). The facemask was connected with an anti-
bacterial filter (PALL PRO1087, Pall, East Hills, NY,
USA) to an Innocor™ device (Innocor™, Innovision,
Odense, Denmark). Pulmonary gas exchange and
ventilation were continuously measured breath by breath
throughout all ergometer trials. Throughout all cycling
tests, heart rate was recorded (Polar S610i, Polar Electro,
Kempele, Finland). V̇ O2peak, V̇ O2 during the constant-
load trials at CP (V̇ O2,CLT), carbon dioxide output during
the constant-load trials at CP (V̇ CO2,CLT), respiratory
exchange ratio during the constant-load trials at CP
(RERCLT) and heart rate during the constant-load trials at
CP (HRCLT) were determined as the highest mean over a
10-s period. The V̇ O2 slow component was calculated as
the difference between the changes in V̇ O2 between min
2 and task failure and between min 2 and 6.
Blood analysis
For the analysis of [HCO3
−], [Na+], pH and actual base
excess (ABE) 125 μl blood from the same earlobe were
always obtained 75 min after the NaHCO3 ingestions
and 15 min before the constant-load trials at CP on 1
and day 5. Blood was collected in a heparinized glass
capillary tube and analyzed using a clinical blood gas
analyzer (ABL 505, Radiometer, Copenhagen, Denmark).
Venous blood samples (4 ml) were collected from the
cubital vein before the constant-load trials at CP on days
1 and 5 (medica, Medizinische Laboratorien Dr. F.
Kaeppeli, Zurich, Switzerland). These blood samples
were analyzed for hemoglobin concentration and
hematocrit, which were used to calculate changes in PV
according to Dill and Costill [26].
Body composition measurement
A densitometer (Lunar iDXA™, GE Healthcare, Madison,
WI, USA) was used for the determination of total lean
body mass and lean soft tissue mass of the legs.
Dual-energy X-ray absorptiometry (DXA) measurements
were performed just before the constant-load trials every
second day throughout the intervention periods to assess
leg lean mass as an indicator of glycogen content.
According to the DXA two-component soft tissue model,
lean soft tissue mainly consists of water, proteins, glycogen
and soft tissue minerals [27]. Water and glycogen content
are further interconnected since each gram of glycogen
binds 3–4 g of water [28]. To ensure a similar provision of
carbohydrates in the immediate post-exercise period,
participants were given 0.75 dm3 of a regeneration drink
(57 g carbohydrates∙ portion−1, Carbo Basic Plus,
Winforce, Menzingen, Switzerland) instantly after
completion of each constant-load trial.
Statistical analysis
To assess differences in Tlim, blood values, gas exchange,
heart rate, and body composition a two-way repeated-
measures ANOVA having two levels of condition
(NaHCO3 and placebo) and five levels of time (5 days of
testing) was used. The assumption of sphericity was
tested using Mauchly’s test. If the assumption of sphericity
was violated, the degrees of freedom were corrected using
the Greenhouse-Geisser estimates of sphericity. When F
ratios were significant, post hoc comparisons of main
effects were performed using a Student’s paired t-test with
Bonferroni correction. PV data were not normally
distributed and thus log-transformed before using the
described analysis. All data are presented as means ± SD.
The effect size is denoted as ηp
2 (partial eta-squared). The
level of significance was set at P < 0.05. The statistical
analyses were conducted using the software SPSS Statistics
20.0 (SPSS, Chicago, IL, USA).
Results
As judged by the leftover pill count, average compliance
with NaHCO3 and placebo supplementation was 100%.
Tlim increased by 23.5% following NaHCO3 ingestion
(F(1,7) = 35.45, P = 0.001, ηp
2 = 0.84; Figure 2a). However,
there was neither an effect of time (F(4,28) = 1.1, P = 0.375,
ηp
2 = 0.14) nor an intervention x time interaction (F(4,28) =
0.74, P = 0.464, ηp
2 = 0.01; Figure 2b). No differences in
CP, as measured before the first and second supple-
mentation period, could be found (306.8 ± 21.4 W vs.
309.0 ± 30.4 W; F(1,7) = 0.15, P = 0.708, ηp
2 = 0.02).
Also, no difference could be found between CP as
determined before the NaHCO3 and placebo intervention
(304.3 ± 25.6 W vs. 311.5 ± 26.5 W; F(1,7) = 1.99, P = 0.202,
ηp
2 = 0.22).
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The NaHCO3 intervention resulted in a significantly
higher [HCO3
−] relative to placebo (F(1,7) = 118.71,
P < 0.001, ηp
2 = 0.94; Table 1). However, there was
neither a main effect for time (F(1,7) = 0.05, P = 0.835,
ηp
2 = 0.01) nor an intervention x time interaction (F(1,7) =
0.04, P = 0.855, ηp
2 = 0.01). [Na+] increased after NaHCO3
(F(1,7) = 12.44, P = 0.012, ηp
2 = 0.68) but remained constant
with placebo supplementation. [Na+] did not significantly
change over time (F(1,7) = 0.49, P = 0.509, ηp
2 = 0.08) with
either condition. The mean ABE were significantly
higher during the NaHCO3 compared to the placebo
trials (F(1,7) = 100.42, P < 0.001, ηp
2 = 0.94), but not
between days of testing (F(1,7) = 0.01, P = 0.920, ηp
2 = 0.00).
Blood pH was increased with NaHCO3 supplementation
(F(1,7) = 42.04, P < 0.001, ηp
2 = 0.86), showing no
change between the testing days (F(1,7) = 1.11, P = 0.327,
ηp
2 = 0.14). There was a main effect for a PV increase
during interventions (F(1,7) = 19.22, P = 0.003, ηp
2 = 0.73;
Table 1) and days of testing (F(1,7) = 18.12, P = 0.004,
ηp
2 = 0.72), as well as a significant intervention x time
interaction (F(1,7) = 22.05, P = 0.002, ηp
2 = 0.76).
The NaHCO3 ingestion resulted in a significant
intervention x time interaction for total lean body mass
(F(1,7) = 7.77, P = 0.027, ηp
2 = 0.53; Table 2). In addition,
total lean body mass raised over the five consecutive
testing days in both conditions (F(2,14) = 10.97, P = 0.001,
ηp
2 = 0.61; Table 2). Lean soft tissue mass of the legs did
not change neither during the interventions (F(1,7) = 3.16,
P = 0.119, ηp
2 = 0.31) nor across the days of testing
(F(2,14) = 1.38, P = 0.283, ηp
2 = 0.17; Table 2).
V̇ O2,CLT and V̇ CO2,CLT did not differ between the
interventions (F(1,7) = 1.453, P = 0.267, ηp
2 = 0.17 and
F(1,7) = 1.132, P = 0.323, ηp
2 = 0.14; Table 3) or between
the days of testing (F(2,14) = 0.631, P = 0.667, ηp
2 = 0.39 and
F(2,14) = 0.145, P = 0.964, ηp
2 = 0.020). None of the daily
V̇ O2,CLT (data not shown) differed from V̇ O2peak (F(2,14) =
0.081, P = 0.923, ηp
2 = 0.011). There was no difference in
the V̇ O2 slow component between the NaHCO3 and
placebo intervention (0.08 ± 0.31 vs. 0.03 ± 0.28 l∙ min−1
for the NaHCO3 and placebo intervention, respectively;
P = 0.504). RERCLT also was not different between inter-
ventions (F(1,7) = 2.947, P = 0.130, ηp
2 = 0.30) and days of
testing (F(2,14) = 0.821, P = 0.523, ηp
2 = 0.11). HRCLT de-
creased during the 5 testing days (F(4,28) = 5.97, P = 0.001,
ηp
2 = 0.46; Table 3) but there was no main effect for
condition (F(1,7) = 0.04, P = 0.852, ηp
2 = 0.01).
Figure 2 Time-to-exhaustion with NaHCO₃ and placebo supplementation. a) Mean ± SD time-to-exhaustion (Tlim) with NaHCO3 and
placebo, respectively, **P < 0.01; b) Tlim with NaHCO3 (solid line) and placebo (dashed line) on the 5 days of testing are presented as group mean
± SD (n = 8).
Table 1 [HCO3
-], [Na+], ABE, pH and PV 75 min after supplement ingestion on the first and the fifth day of testing with
either NaHCO3 or placebo supplementation
NaHCO3 Placebo
Day 1 Day 5 Day 1 Day 5
[HCO3
-] (mmol ⋅l-1) 32.4 ± 1.8*** 32.6 ± 2.7*** 26.4 ± 1.8 26.0 ± 1.1
[Na+] (mmol ⋅l-1) 142.1 ± 3.9* 142.4 ± 3.0* 138.1 ± 1.2 139.3 ± 5.5
ABE (mmol ⋅l-1) 8.4 ± 1.7*** 8.3 ± 2.3*** 2.7 ± 1.7 2.0 ± 0.9
pH 7.49 ± 0.02*** 7.48 ± 0.02*** 7.44 ± 0.02 7.43 ± 0.02
PV (%) 55.5 ± 2.3 62.6 ± 3.8†† 56.0 ± 1.7 55.9 ± 3.3
Values are mean ± SD (n = 8). [HCO3
-], blood bicarbonate concentration; [Na+], blood sodium concentration; ABE, actual base excess; PV, plasma volume.
*P < 0.05, *** P < 0.001 relative to placebo at the same time point; †† P < 0.01 relative to day 1.
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Discussion
Several new findings have been observed in this ran-
domized, placebo-controlled, double-blind interven-
tional crossover investigation. First, multiday NaHCO3
supplementation for 5 days increased Tlim at CP on each
day relative to placebo in highly trained athletes. Second,
there was no difference in the increased Tlim over the
5 days of supplementation with NaHCO3 or NaCl.
Third, the increase in Tlim was paralleled by increases
in [HCO3
−], pH and ABE. Fourth, [HCO3
−] and [Na+] in
the blood stabilized over time in the NaHCO3 condition.
Fifth, calculated PV increased during the NaHCO3 more
than in the placebo intervention.
We found that NaHCO3 supplementation led to an
increase in Tlim at CP and that the improvement in Tlim
was paralleled by an increase in blood [HCO3
−], pH and
ABE, indicating that the alteration in Tlim appears to be
linked to an elevated extracellular buffer capacity. In
fact, it has been shown that an increased [HCO3
−] gradi-
ent between the intra- and extramyocellular compart-
ment leads to an amplified H+-efflux from the muscle
cell and delays the fall in intramyocellular pH [8,14]. We
observed a trend for higher [La−] during the constant-
load tests following NaHCO3 supplementation (P = 0.070,
data not shown), supporting the notion that the increased
H+-concentration resulted from a lactate-proton symport.
A fall in intramyocellular [H+] is associated with muscle
fatigue due to 1) an inhibition of glycogenolysis and
glycolysis [8], 2) increased muscular K+ release, 3) lesser
contractility of the heart muscle [9], 4) inhibition of the
sarcoplasmatic calcium release [10] and 5) inhibition of
the actin-myosin interactions [11]. Thus, delaying the fall
in intramyocellular pH might postpone the fatigue process
and prolong intact muscle function. Indeed, our results
showed that the ingestion of NaHCO3 induced metabolic
alkalosis, which in turn enhanced Tlim at CP and thus
improved high-intensity exercise in the range of 10 to
20 min duration.
As hypothesized, Tlim at CP could be increased with
NaHCO3 supplementation. This is in contrast to the
theoretical model, which states that an intramyocellular
metabolic steady state exists at exercise intensities up to
CP. However, our results support the notion that CP over-
estimates the metabolic steady state [4,5]. Furthermore,
our result that NaHCO3 increased Tlim at CP extends
previous findings showing that NaHCO3 supplementation
increases exercise above CP relative to placebo [14,29]. In
the latter studies, short high-intensity tests, during which
intramyocellular pH falls rapidly from the beginning of
exercise, were completed. During these types of tests, the
finite work capacity above CP (W0) is drawn on after the
start of exercise and becomes reduced. In light of our
findings, these results might be interpreted to mean that
NaHCO3 simply increases W’. However, Vanhatalo et al.
[23] showed that NaHCO3 does not increase W’ during
a 3-min all-out test, and concluded that changes in
intramyocellular pH might not influence W’ in this
particular test setting, and that for short all-out exercise,
[PCr] dynamics is more important in determining W’. In
our constant-load trials at CP, W’ was supplied to a large
extent by anaerobic glycolysis. Therefore, we assume that
NaHCO3 supplementation increases W’ in conditions
where acidification occurs during exercise. Our result that
the estimated V̇ O2 slow component was not different
between the two interventions lends further credence to
this notion, although the influence of NaHCO3 on the V̇ O2
slow component remains ambiguous (reduction: [30]; no
change: [31]). In our study, the identical V̇ O2 slow
component for both, the NaHCO3 and placebo condition,
indicated that V̇ O2peak was attained at the same point in
time. Based on the fact that the depletion of W’ coincides
with the attainment of V̇ O2peak [32], our results indicate
that NaHCO3 ingestion did not increase the rate of W’
utilization but rather W’ itself. Further support for our
assumption comes from another study, where average
power in a 60 min cycling time trial was found to be
Table 2 Total lean body mass and lean soft tissue mass of the legs on the different days of testing with either NaHCO3
or placebo ingestion
NaHCO3 Placebo
Day 1 Day 3 Day 5 Day 1 Day 3 Day 5
Total lean soft tissue (kg) 60.7 ± 4.8 61.7 ± 5.3*†† 62.0 ± 5.3*†† 60.5 ± 5.3 61.3 ± 5.4†† 60.6 ± 5.0
Lean soft tissue legs (kg) 21.1 ± 2.5 21.3 ± 2.9 21.4 ± 3.0 21.0 ± 2.9 21.2 ± 2.9 21.0 ± 2.9
Values are mean ± SD (n = 8). *P < 0.05 relative to placebo; †† P < 0.01 relative to day 1.
Table 3 Peak values during the CLT at CP for VO2, VCO2,
RER and HR on the first and fifth day of testing with
either NaHCO3 or placebo supplementation
NaHCO3 Placebo
Day 1 Day 5 Day 1 Day 5
VO2,CLT 4.64 ± 0.39 4.66 ± 0.30 4.59 ± 0.37 4.64 ± 0.47
VCO2,CLT 4.63 ± 0.47 4.67 ± 0.19 4.58 ± 0.36 4.59 ± 0.40
RERCLT 1.07 ± 0.04 1.08 ± 0.05 1.03 ± 0.05 1.05 ± 0.05
HRCLT 177.4 ± 8.5 172.8 ± 9.0** 176.3 ± 7.8 173.8 ± 8.6**
Values are mean ± SD (n = 8). CLT, constant-load trials; CP, ‘Critical Power’;
VO2, oxygen uptake; VCO2 carbon dioxide output; RER, respiratory exchange
ratio; HR, heart rate. ** P < 0.01 relative to day 1.
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higher with NaHCO3 as compared to placebo [33]. During
a 60 min time trial, power output will fluctuate around CP
with power peaks occurring e.g. at the start and during
(final) sprints. In these occasions, i.e. when exercising
above CP, W’ will be reduced. Consequently, a higher W’
can increase performance during tests of longer duration,
especially if pacing strategies are implemented.
We also found that five bolus intakes on five consecutive
days did not result in an increase of Tlim beyond the value
observed after the first intake. Thus, multiday administra-
tion of NaHCO3 did not lead to a cumulative effect on
endurance capacity. Accordingly, [HCO3
−], blood pH,
and ABE after multiday NaHCO3 administration also
remained unchanged relative to the initial rise after the
first bolus. The most obvious explanation would be that
during each CP-trial a certain amount of NaHCO3 was
used, leading to lower values for [HCO3
−], pH and ABE
post vs. pre test. During the following 24 h of recovery,
the body would then be expected to re-establish the
resting values. On the following day, the participants then
would start the CP trial at similar (complete recovery) or
lower [HCO3
−], blood pH, and ABE (incomplete recovery)
relative to the first day, whereby an additional increase in
performance would not be expected. Although we did not
measure [HCO3
−], pH and ABE before supplementation
on the following days, these two described cases can be
most likely excluded. The reason for this is that [Na+] also
did not increase during the consecutive 5 days of
NaHCO3 supplementation despite the fact that Na
+,
unlike HCO3
−, was not used as a buffer during the CP
trials, and that the high amount of ingested Na+ could not
be used completely through sweating. The predicted
sweating rate during exercise of 1 dm3∙ h−1 water, with a
sweat [Na+] of 50 mEq∙ dm3 [34] would have led to a Na+
loss of ~0.36 g. This calculated sweat-induced loss of Na+
corresponds to ~20% of the daily Na+ intake during the
placebo intervention. Regarding the substantially higher
Na+ intake during the NaHCO3 intervention, the
sweat-induced loss of Na+ was negligible during this
intervention.
As shown in this study, the NaHCO3 intervention led to
an increase in [Na+] and plasma osmolality after the first
bolus administration. This increase was counteracted by
an expansion in PV. The increase in PV was to such an
extent that pre-exercise blood [HCO3
−], pH, and ABE
remained constant during the 5 days of testing. This
proposed mechanism of PV expansion has already been
described by Máttar et al. [35], who showed that plasma
[Na+] and plasma osmolality were increased after
NaHCO3 injections in acute cardiac resuscitation. Other
mechanisms to counteract increases in [Na+] and plasma
osmolality comprise a shift of fluid from the intra- to the
extramyocellular compartment [36], a stimulation of
arginine vasopressin secretion [37], which leads to an
intensified water retention from the kidneys [38], and a
stimulation of the thirst center whereby more fluid is con-
sumed [37]. In accordance with our results, McNaughton
et al. [29] found an increase in plasma [Na+] after the first
of five doses of NaHCO3 but no further increase of plasma
[Na+] on the following days. The elevation of PV in the
present study is mirrored by the measured increase in
DXA whole-body lean mass. In the DXA two-component
soft tissue model, lean mass comprises water, proteins,
glycogen and non-bone minerals [27]. As increases in
protein, glycogen and non-bone minerals can virtually be
excluded (see below), the increase in whole-body lean
mass must have resulted from an increase in whole body
water, which led to an expansion in PV. Our findings are
in accordance with the report of Lands et al. [39] who
found a significantly higher value for DXA-derived
whole-body lean mass after saline infusion given to
healthy male participants. Finally, our finding that
HRCLT was reduced lends further credence to our result
that PV increased as a consequence of NaHCO3 supple-
mentation, because PV expansion simultaneously increases
stroke volume and reduces sympathetic nervous activity,
leaving V̇ O2,CLT unaffected [40].
In our study, DXA-derived leg lean mass did neither
change between interventions nor over time (Table 2).
As with each gram of glycogen stored in muscle tissue
3–4 g of water is bound [28], and body water is present
within the lean soft tissue compartment [27], a decrease
in leg lean mass in such a short time (2 days) would
indicate a loss of glycogen. In turn, glycogen loss
would implicate incomplete regeneration, which would
manifest itself in a reduced anaerobic work capacity and,
accordingly, decreased performance [41]. Since our
participants displayed neither a reduction in leg lean
mass nor performance, the provided regeneration drink
and the participants’ daily nutritional intake were
sufficient to restore glycogen from day to day, allowing
them to perform maximally on each day.
Our results have at least two practical implications. First,
since the [HCO3
−] gradient between intramyocellular
compartment and blood did not decrease over time,
NaHCO3 can be taken daily in multiday competitions or
tournaments lasting ≤ 5 d without the risk of reducing
performance. Second, the apparent PV expansion in
response to the high ion intake (see above) blunted any
further increase in [HCO3
−]. If the same mechanism
would be true for the chronic supplementation protocol,
the effectiveness of this protocol should be questioned, as
it seems that [HCO3
−] cannot be increased limitlessly, i.e.
that it probably reaches a ceiling. The observed ceiling
effect was probably based on a metabolic compensation
mechanism preventing a disproportionate increase in
[HCO3
−]. A respiratory compensation mechanism is
unlikely to have occurred in our study because there were
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no differences between the NaHCO3 and placebo
intervention for V̇ CO2 (P = 0.903, data not shown) and
RER (P = 0.556, data not shown) during the resting
measurements before the constant-load tests. Of further
note is that the standard chronic protocol comprises a
daily dose of 0.5 g NaHCO3 kg
−1 body mass [42], which
might accentuate the increase in PV and possible side
effects. Thus, one adequate dose of NaHCO3 administered
before the competition should be effective in mediating all
of the performance-enhancing effects without the need of
a “loading phase”. In this context, our results expand the
findings of McNaughton and Thompson [16] as well as
Siegler et al. [17], who compared different acute and
chronic protocols and found that there are no differences
between these ingestion protocols with respect to exercise
performance.
It may be argued that the present findings could be
limited by 1) differences in performance ability throughout
the study period and 2) decreasing motivation. Regarding
the first point we have shown that CP was neither
different between the first and second intervention period
nor before the NaHCO3 and placebo condition. An
increase in CP from the first to the second intervention
would have indicated a training effect, whereas a decrease
in CP would have indicated incomplete recovery. Hence,
we can assume that the participants had the same
performance ability throughout the study, allowing a com-
parison of Tlim between the two conditions. Regarding the
second point, decreasing motivation in a single participant
would be evident from a decrease in Tlim within or
between interventions. Considering the single variations
in Tlim irrespective of condition, during which no distinct
increases or decreases in Tlim over time (i.e. from the
second to the fifth test day) were identified, a decreasing
motivation can be excluded for all participants. In
addition, V̇ O2,CLT, V̇ CO2,CLT and RERCLT were not
different between conditions and days of testing. This
indicates that the participants’ effort was constant during
the whole study period.
Conclusion
In conclusion, multiple acute, consecutive day NaHCO3
supplementation led to an increase in Tlim at CP after
the first bolus intake. However, while Tlim remained
elevated in the NaHCO3 condition, it was not further
altered with prolonged NaHCO3 supplementation. The
increase in Tlim was accompanied by a higher [HCO3
−]
gradient between the blood and the intramyocellular com-
partment, which stabilized over time in the NaHCO3
intervention. In contrast to the theoretical CP-model,
where metabolites should reach a steady state during exer-
cise at CP, and consequently, buffer substances should be
ineffective in enhancing Tlim, we showed that in practice
Tlim can be increased with NaHCO3 supplementation.
Furthermore, the high amount of ingested Na+ caused a
sustained elevation in PV, which inhibited a further in-
crease in [HCO3
−], and consequently limited the
performance-enhancing effect. Therefore, this study indi-
cates that NaHCO3 can be taken daily in multiday compe-
titions or tournaments to maintain performance ability
throughout the whole duration of the competition.
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